Results 161 to 170 of about 1,533 (199)
Some of the next articles are maybe not open access.
Intelligent Micro‐/Nanorobots for Cancer Theragnostic
Advanced Materials, 2022AbstractCancer is one of the most intractable diseases owing to its high mortality rate and lack of effective diagnostic and treatment tools. Advancements in micro‐/nanorobot (MNR)‐assisted sensing, imaging, and therapeutics offer unprecedented opportunities to develop MNR‐based cancer theragnostic platforms.
Jie Wang +7 more
openaire +2 more sources
PET and SPECT in Cancer Theragnostics
The optimal drug regimen in cancer therapeutics is one with the best chance to cure an individual patient while reducing risks and toxicity. Major determinants of individual tumor response to a given therapeutic regimen are the specific gene expression ...
DEL VECCHIO, SILVANA +1 more
openaire +2 more sources
Alpha and Beta Radiation for Theragnostics
PET ClinicsTargeted radionuclide therapy (TRT) has significantly evolved from its beginnings with iodine-131 to employing carrier molecules with beta emitting isotopes like lutetium-177. With the success of Lu-177-DOTATATE for neuroendocrine tumors and Lu-177-PSMA-617 for prostate cancer, several other beta emitting radioisotopes, such as Cu-67 and Tb-161, are ...
Hong, Song, George, Sgouros
openaire +2 more sources
Nanoparticles in Oncology: The New Theragnostic Molecules
Anti-Cancer Agents in Medicinal Chemistry, 2011Cancer nanotherapeutics have shown promise in resolving some of the limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, low therapeutic indices, and poor oral bioavailability. Moreover, cancer nanotechnology has the potential of improving current approaches to cancer detection ...
ALLEGRA, Alessandro +5 more
openaire +3 more sources
Theragnostic implications of exosomes in preeclampsia
Hypertension Research, 2021Sushmaa Chandralekha, Selvakumar +3 more
openaire +2 more sources
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years
Current Medical Imaging, 2023Michele Balma +2 more
exaly

